Subscribe To
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am